Epidemiological assessment of adverse events following measles, mumps, and rubella (MMR) vaccination
This is a self-controlled case series (SCCS) study of a cohort of children aged 0–5 years who were born in 2008–2019 and are resident in New Zealand to investigate the association between MMR vaccination and a list of specified conditions.
African COVID-19 Vaccine Safety Surveillance (ACVaSS)
The GVDN® is a technical partner with the African COVID-19 Vaccine Safety Surveillance (ACVaSS) project.* Hospital-based sentinel surveillance designed to detect safety signals of rare adverse events of special interest (AESIs) or to evaluate safety signals arising from other sources, following vaccination with COVID-19 vaccines, is being implemented in eight in African Advanced Market Commitment-92 (AMC-92) eligible countries in the Alive (African Leadership in Vaccinology Expertise) Network: Mali, Ghana, Nigeria, Ethiopia, Kenya, Malawi, Mozambique, Eswatini.
Helen Petousis-Harris PhD, PGDipSci(Dist), BSc
Helen Petousis-Harris PhD, PGDipSci(Dist), BSc
Co-Director
Helen Petousis-Harris PhD, PGDipSci(Dist), BSc
Co-Director
ID
586
How vaccine safety data is constantly misused and what you can do
Given the breadth and magnitude of vaccine safety activities, it is surprising how wide the belief is that the world relies on voluntary reports of adverse events, even among health professionals. That this science is so misunderstood provides fertile ground for anti-vaccine messages to propagate. Here is some information to help challenge the misconceptions.
Han (Hannah) Lu PhD(c), MSc, BSc
Han (Hannah) Lu PhD(c), MSc, BSc
Biostatistician
ID
541